[Special Stock] Miko Rises on Subsidiary's Inclusion in WHO Certification List for COVID-19 Diagnostic Kit

Sujentek, Labgenomics, and Others Also on the Rise

[Asia Economy Reporter Minwoo Lee] Miko's stock price is showing a strong upward trend. The news that its subsidiary, MikobioMed's COVID-19 diagnostic kit, has been listed on the certification list of FIND, a non-profit organization cooperating with the World Health Organization (WHO), appears to have acted as a positive factor. Additionally, other diagnostic kit-related stocks such as Suzentec and LabGenomics are generally showing strength.

According to the Korea Exchange as of 1:25 PM on the 10th, Miko's stock price is trading at 9,670 KRW, up about 5.3% from the previous day. The price increase seems to be driven by the news that MikobioMed's diagnostic kit was included in the certification list of FIND, a Switzerland-based non-profit organization. FIND collaborates with more than 150 partners to develop, evaluate, and commercialize diagnostic tools for various diseases. Typically, once recognized by FIND, diagnostic kits can be supported and supplied to developing countries and others through WHO and the Bill & Melinda Gates Foundation.

Meanwhile, due to the strong presence of COVID-19, the stock prices of various diagnostic kit companies are rising. Suzentec is trading at 13,900 KRW, up 6.51% from the previous day, and LabGenomics is trading at 16,350 KRW, up more than 15%.

This content was produced with the assistance of AI translation services.